Thank you for correcting the text in this article. Your corrections improve Papers Past searches for everyone. See the latest corrections.

This article contains searchable text which was automatically generated and may contain errors. Join the community and correct any errors you spot to help us improve Papers Past.

Article image
Article image
Article image
Article image
Article image
Article image

“INFLUENZA CURE."

OFFICIAL RECOGNITION OF DR DOYEN’S NEW THERAPEUTIC PREPARATION.

Experiments with' Dr. Doyen’s new therapeutic preparation,, mycolysine, have given such excellent results that the French Ministers of Marine and the Colonies have issued orders that mycolysine and ether preparations of which it is the basis shall in future he included in the medicaments authorised. The reports received showed that mycolysine prevented and cured influenza, respiratory diseaess, enteritis, infantile diarrhoea, and other infectious complaints, as well as diseases peculiar to warm climates and, therefore, prevalent in the Colonies. Its therapeutic efficacy may he gauged by the fact that it increases tenfold the power of resistance to the inroads of malignant germs, and it is therefore hailed in Paris as a boon to humanity.

Permanent link to this item
Hononga pūmau ki tēnei tūemi

https://paperspast.natlib.govt.nz/newspapers/GIST19130312.2.67

Bibliographic details
Ngā taipitopito pukapuka

Gisborne Times, Volume XXXIV, Issue 3777, 12 March 1913, Page 8

Word count
Tapeke kupu
123

“INFLUENZA CURE." Gisborne Times, Volume XXXIV, Issue 3777, 12 March 1913, Page 8

“INFLUENZA CURE." Gisborne Times, Volume XXXIV, Issue 3777, 12 March 1913, Page 8

Help

Log in or create a Papers Past website account

Use your Papers Past website account to correct newspaper text.

By creating and using this account you agree to our terms of use.

Log in with RealMe®

If you’ve used a RealMe login somewhere else, you can use it here too. If you don’t already have a username and password, just click Log in and you can choose to create one.


Log in again to continue your work

Your session has expired.

Log in again with RealMe®


Alert